Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib Dose Escalation in Advanced Renal Cell Cancer
NCT01189370Phase 2Completed
- Sponsor
- University of Kansas Medical Center
- Start
- Jun 2008
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in renal cell carcinoma (RCC), sponsored by University of Kansas Medical Center. Started Jun 2008; status: completed.
02
Drugs
sorafenib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01189370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01189370.